Anika Therapeutics (ANIK) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $14.70 +3.52%
EPS Growth %: +115.4%
Financial Fact:
Net income: 0.61
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: +115.4%
Financial Fact:
Net income: 0.61
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Anika Therapeutics (NASDAQ: ANIK) reported Q1 EPS of $0.37, $0.01 worse than the analyst estimate of $0.38. Revenue for the quarter came in at $23.4 million versus the consensus estimate of $23.89 million.
For earnings history and earnings-related data on Anika Therapeutics (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- Qualcomm investor day to detail data center plans Wednesday
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
